Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 2/20 | 0.65 |
| ▸ | ERN1 | O75460 | 4/20 | 0.64 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.58 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.58 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | ESR1 | P03372 | 9/20 | 0.51 |
| ▸ | ESR2 | Q92731 | 9/20 | 0.51 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | ACLY | P53396 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31026679 | 0.82 | APP (0.58) | APPERN1HSD17B1HSD17B2CA1 | |
| SCHEMBL7503046 | 0.82 | APP (0.58) | APPERN1HSD17B1HSD17B2CA1 | |
| SCHEMBL32677328 | 0.80 | APP (0.81) | APPERN1HSD17B1HSD17B2CA1 | |
| SCHEMBL27159530 | 0.80 | APP (0.81) | APPERN1HSD17B1HSD17B2CA1 | |
| SCHEMBL6172601 | 0.79 | APP (1.00) | APPERN1HSD17B1HSD17B2CA1 | |
| SCHEMBL12767811 | 0.78 | ERN1 (1.00) | APPERN1HSD17B1HSD17B2CA1 | |
| SCHEMBL28813263 | 0.78 | APP (0.67) | APPERN1HSD17B1HSD17B2CA1 | |
| SCHEMBL5384482 | 0.77 | APP (0.65) | APPERN1HSD17B1HSD17B2CA1 | |
| SCHEMBL5429670 | 0.77 | APP (0.75) | APPERN1HSD17B1HSD17B2CA1 | |
| SCHEMBL27631114 | 0.76 | HSD17B1 (0.77) | APPERN1HSD17B1HSD17B2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8758960-B2 | Photoreactive composition, optical material, composition for forming holographic recording layer, holographic recording material, and holographic recording medium | MITSUBISHI CHEMICAL CORPORATION (JP) | 2014-06-24 | — | — | US | disclosed |
| US-20110092612-A1 | PHOTOREACTIVE COMPOSITION, OPTICAL MATERIAL, COMPOSITION FOR FORMING HOLOGRAPHIC RECORDING LAYER, HOLOGRAPHIC RECORDING MATERIAL, AND HOLOGRAPHIC RECORDING MEDIUM | MITSUBISHI CHEMICAL CORPORATION (JP) | 2011-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110092612-A1 | PHOTOREACTIVE COMPOSITION, OPTICAL MATERIAL, COMPOSITION FOR FORMING HOLOGRAPHIC RECORDING LAYER, HOLOGRAPHIC RECORDING MATERIAL, AND HOLOGRAPHIC RECORDING MEDIUM | MKI67, RRS1, NAP1L1 | APP 839/4885ERN1 2243/4885HSD17B1 1662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.